Sign In
News Digest /
Ticker: PFE
Ticker: PFE
06:42am, Tuesday, May 05, 2026
Heightened US-Iran clashes near the Strait of Hormuz push oil prices above $100, weighing on Asian and European shares while the yen faces intervention speculation. Key earnings and US job data loom.
07:40am, Monday, Mar 23, 2026
Pfizer and Valneva announce plans to seek approval for a Lyme disease vaccine after a Phase 3 trial showed over 70% efficacy but missed its primary statistical target.
09:53am, Tuesday, Feb 03, 2026
Pfizer's once-a-month drug leads to up to 12% weight loss in patients, suggesting a potent new option in weight management therapies. Early study results highlight significant impact.
07:44am, Thursday, Nov 20, 2025
Moderna lands a $1.5 billion loan from Ares Management and forecasts a 10% revenue lift next year despite recent pipeline cuts. The biotech readies new vaccine launches to reclaim market share.
06:25am, Monday, Nov 10, 2025
Norway's sovereign wealth fund abstains from crucial Novo Nordisk board vote amid leadership reshuffle. Meanwhile, Pfizer clinches $10B deal for Metsera, sidelining Novo in obesity drug race.
09:12am, Tuesday, Nov 04, 2025
Pfizer outperforms Q3 earnings forecasts and raises full-year profit guidance even as sales decline, driven by strategic cost cuts and ongoing challenges in the Covid product line.
09:08am, Tuesday, Nov 04, 2025
Michael Burry's Scion Asset Management reveals new put positions on Nvidia and Palantir, signaling skepticism amid recent stock surges and talk of potential market bubbles.
04:44am, Tuesday, Oct 28, 2025
Novartis CEO Vas Narasimhan insists major acquisitions remain on the table, spotlighting the $12B Avidity deal amid a strong cash flow and steady sales growth despite generic pressure.
09:21am, Friday, Sep 26, 2025
Premarket: tariff chatter lifts chips & pharma-Intel (INTC) +3.7%, GlobalFoundries (GFS) jumps; J&J (JNJ), Pfizer, Lilly firmer after 100% branded-drug tariff talk. Boeing (BA) up on orders; Wayfair (W) down on furniture tariffs. Volatility likely.
07:31am, Monday, Sep 22, 2025
Pfizer to Buy Metsera for Up to $7.3B - $47.50/Share Cash (43% Premium), Metsera Pops ~56% Premarket
Pfizer to buy Metsera for up to $7.3B - $47.50/share plus $22.50 in milestones (~43% premium). Metsera jumped ~56% premarket. Deal fast-tracks Pfizer into the obesity drug race with Eli Lilly and Novo Nordisk.
06:38am, Tuesday, Aug 19, 2025
Study: RFK Jr.'s June firing came as ACIP reported conflicts fell to ~5% in 2024; FDA VRBPAC has stayed under 4% since 2010. Traders: the shakeup raises short‑term regulatory uncertainty for vaccine stocks like PFE, MRNA and JNJ.
07:02am, Wednesday, Aug 06, 2025
Trump's tariff moves reshape global trade, easing EU tensions but hiking duties on copper and low-value imports. Key deadlines in August-September may escalate US-China friction and pressure drugmakers like Eli Lilly and Pfizer on pricing.
03:37pm, Tuesday, Aug 05, 2025
The S&P 500 dipped as weaker US services data raised growth concerns. Earnings from Palantir and Pfizer impressed, while Marriott and Caterpillar showed mixed results amid trade relief and Fed rate cut talks. Market caution persists.
03:36pm, Tuesday, Aug 05, 2025
Pfizer (NYSE: PFE) raised its profit outlook despite higher import tariffs boosting costs. Strong demand and strategic pricing help offset expenses, showcasing resilience amid global trade challenges as the pharma giant aims for a solid year-end finish.
07:11am, Tuesday, Apr 29, 2025
Pfizer (NYSE: PFE) has initiated cost-reduction strategies while exceeding quarterly profit forecasts despite an 8% sales decline due to waning Covid-related revenue. The company aims for $4.5B in savings by 2025, maintaining its 2025 sales guidance of $61B-$64B amidst uncertainty.
06:56am, Tuesday, Feb 04, 2025
Key companies reporting earnings on February 4, 2025, include Google (GOOGL, GOOG), Toyota (TM), Merck (MRK), Pfizer (PFE), Pepsico (PEP), and AMD (AMD). Investors should watch for insights that could influence market sentiment and stock movements.
09:51am, Tuesday, Dec 17, 2024
Pfizer (NYSE: PFE) reassures investors by aligning 2025 profit projections with market expectations, causing a 3% stock rise. Despite challenges from dwindling COVID-19 revenue and management criticism, forecasts predict profits of $2.80-$3 per share and revenues of $61-$64 billion.
09:13am, Tuesday, Oct 29, 2024
Tuesday Markets: stocks rise with key earnings reports ahead. Ford (F) adjusts earnings guidance, while Lucid (LCID) announces SUV pricing and strategic moves to expand production.
08:44am, Tuesday, Oct 29, 2024
**Upcoming Earnings Report Alert: October 29, 2024**
Major companies announcing earnings today include Visa, AMD, Stryker, McDonald's, Novartis, Pfizer, and HSBC. Watch for insights into consumer trends, healthcare growth, and market uncertainties! Stay tuned for detailed analysis.
04:35am, Thursday, Oct 10, 2024
Pfizer (NYSE: PFE) shares rose over 3%, outperforming the S&P 500, following news of CEO Albert Bourla’s upcoming talks with activist investor Starboard Value, which recently acquired a $1 billion stake. Investors are hopeful for strategic changes to revive the company's momentum.
08:28am, Monday, Sep 16, 2024
Week 38: The Federal Reserve may cut rates this week, DirecTV resolves ESPN blackout, and Boeing faces financial strain amid a growing labor strike.
08:30am, Friday, Jul 26, 2024
Thorough guide to selecting dividend stocks: focus on sector selection, financial ratios, management quality, risk assessment, and portfolio diversification to balance income and growth opportunities.
08:51am, Tuesday, Jul 09, 2024
S&P 500 and Nasdaq hit record highs. Key inflation data and Fed testimony in focus. Crude prices dip post-Hurricane Beryl. Netflix stock rises. These and more in today's market recap.
07:48am, Monday, Jul 08, 2024
Pfizer (NYSE: PFE) stock has faced a significant dip, dropping over 50% since late 2021. Despite this, the company remains a strong dividend performer, boasting a 6.1% yield. With strategic acquisitions and robust new drug approvals, Pfizer projects adjusted earnings of $2.15-$2.35 per share for ...
06:57am, Thursday, Jun 13, 2024
Top investors are turning to high-yield dividend stocks despite market buzz. Key picks include Verizon Communications (NYSE: VZ) with a 6.58% yield, Pfizer (NYSE: PFE) at 5.99%, and AGNC Investment (NASDAQ: AGNC) boasting a 15.06% yield.
08:01am, Tuesday, May 21, 2024
Hedge funds and notable investors are capitalizing on the current low prices of Pfizer (NYSE: PFE) stock, showing increased interest in the pharmaceutical giant amidst market fluctuations.
08:58am, Tuesday, Apr 09, 2024
Latest stock market news covers Biden's student debt plan, Binance’s fresh start, Spirit Airlines’ strategy shift, and upcoming earnings reports.
06:03am, Tuesday, Apr 09, 2024
Billionaire Ken Griffin has significantly increased his stake in Pfizer (NYSE: PFE), raising eyebrows. With forward earnings multiple far below the S&P 500 and a 6.3% dividend yield, is Pfizer a hidden gem in a volatile market?